Fidelity Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32M Buy
254,844
+158,926
+166% +$20M ﹤0.01% 1550
2025
Q1
$10.6M Sell
95,918
-43,744
-31% -$4.84M ﹤0.01% 1889
2024
Q4
$19.1M Sell
139,662
-106,444
-43% -$14.5M ﹤0.01% 1745
2024
Q3
$28.4M Sell
246,106
-95,723
-28% -$11M ﹤0.01% 1589
2024
Q2
$47.1M Buy
341,829
+109,310
+47% +$15M ﹤0.01% 1334
2024
Q1
$32.1M Sell
232,519
-32,033
-12% -$4.42M ﹤0.01% 1486
2023
Q4
$34.9M Buy
264,552
+242,547
+1,102% +$32M ﹤0.01% 1428
2023
Q3
$2.48M Buy
22,005
+12,420
+130% +$1.4M ﹤0.01% 2233
2023
Q2
$904K Sell
9,585
-22,990
-71% -$2.17M ﹤0.01% 2497
2023
Q1
$3.3M Sell
32,575
-753,973
-96% -$76.3M ﹤0.01% 2231
2022
Q4
$93.9M Buy
786,548
+443,868
+130% +$53M 0.01% 990
2022
Q3
$36.4M Buy
342,680
+109,175
+47% +$11.6M ﹤0.01% 1371
2022
Q2
$22.8M Sell
233,505
-6,156
-3% -$600K ﹤0.01% 1598
2022
Q1
$22.5M Sell
239,661
-434,980
-64% -$40.8M ﹤0.01% 1729
2021
Q4
$57.5M Sell
674,641
-2,790,506
-81% -$238M ﹤0.01% 1367
2021
Q3
$332M Sell
3,465,147
-763,211
-18% -$73.2M 0.03% 591
2021
Q2
$412M Sell
4,228,358
-2,873,730
-40% -$280M 0.03% 510
2021
Q1
$691M Sell
7,102,088
-1,254,990
-15% -$122M 0.06% 317
2020
Q4
$801M Sell
8,357,078
-346,668
-4% -$33.2M 0.07% 267
2020
Q3
$837M Buy
8,703,746
+337,012
+4% +$32.4M 0.08% 212
2020
Q2
$1.02B Buy
8,366,734
+1,083,313
+15% +$132M 0.11% 164
2020
Q1
$630M Sell
7,283,421
-29,215
-0.4% -$2.53M 0.09% 208
2019
Q4
$786M Sell
7,312,636
-1,316,144
-15% -$141M 0.09% 222
2019
Q3
$778M Sell
8,628,780
-577,016
-6% -$52M 0.09% 212
2019
Q2
$777M Sell
9,205,796
-1,231,257
-12% -$104M 0.09% 214
2019
Q1
$920M Sell
10,437,053
-2,579,538
-20% -$227M 0.11% 176
2018
Q4
$930M Sell
13,016,591
-473,255
-4% -$33.8M 0.13% 142
2018
Q3
$1.66B Buy
13,489,846
+38,645
+0.3% +$4.75M 0.19% 94
2018
Q2
$1.32B Buy
13,451,201
+60,325
+0.5% +$5.93M 0.15% 126
2018
Q1
$1.11B Buy
13,390,876
+117,108
+0.9% +$9.71M 0.13% 153
2017
Q4
$1.03B Buy
13,273,768
+40,738
+0.3% +$3.16M 0.12% 172
2017
Q3
$811M Buy
13,233,030
+22,007
+0.2% +$1.35M 0.1% 212
2017
Q2
$608M Buy
13,211,023
+1,180,874
+10% +$54.3M 0.08% 274
2017
Q1
$521M Sell
12,030,149
-919,926
-7% -$39.8M 0.07% 310
2016
Q4
$501M Sell
12,950,075
-51,727
-0.4% -$2M 0.07% 319
2016
Q3
$658M Buy
13,001,802
+304,995
+2% +$15.4M 0.09% 244
2016
Q2
$577M Sell
12,696,807
-270,800
-2% -$12.3M 0.08% 273
2016
Q1
$513M Buy
12,967,607
+38,464
+0.3% +$1.52M 0.07% 286
2015
Q4
$731M Buy
12,929,143
+48,165
+0.4% +$2.72M 0.1% 215
2015
Q3
$513M Buy
12,880,978
+1,819,038
+16% +$72.4M 0.07% 292
2015
Q2
$528M Sell
11,061,940
-828,214
-7% -$39.6M 0.07% 323
2015
Q1
$472M Buy
11,890,154
+489,381
+4% +$19.4M 0.06% 366
2014
Q4
$255M Buy
11,400,773
+12,863
+0.1% +$287K 0.03% 572
2014
Q3
$178M Buy
11,387,910
+12,515
+0.1% +$196K 0.02% 700
2014
Q2
$169M Buy
11,375,395
+76,809
+0.7% +$1.14M 0.02% 745
2014
Q1
$182M Buy
11,298,586
+1,197,077
+12% +$19.3M 0.03% 687
2013
Q4
$94.3M Buy
10,101,509
+42,167
+0.4% +$394K 0.01% 1011
2013
Q3
$114M Buy
10,059,342
+600,130
+6% +$6.79M 0.02% 889
2013
Q2
$127M Buy
+9,459,212
New +$127M 0.02% 804